CREB3L1 as a Potential Biomarker Predicting Response of Triple Negative Breast Cancer to Doxorubicin-Based Chemotherapy
BMC Cancer - United Kingdom
doi 10.1186/s12885-018-4724-8
Full Text
Open PDFAbstract
Available in full text
Date
August 13, 2018
Authors
Publisher
Springer Science and Business Media LLC